Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today’s Top S&P 500 Performers.
Idexx Laboratories stock was rising sharply Monday, even as the S&P 500 and major indexes remained in the red. The Dow Jones ...
These Stocks Moved the Most Today: Tesla, GM, Nvidia, Constellation Brands, Idexx, Palantir, and More
Electric-vehicle maker Tesla and traditional auto manufacturers General Motors and Ford fall but claw back losses with the ...
IDEXX stock jumps 12% as Q4 report, outlook top Street estimates
IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 ...
Idexx Laboratories price target raised to $535 from $475 at BofA
BofA analyst Michael Ryskin raised the firm’s price target on Idexx Laboratories (IDXX) to $535 from $475 and keeps a Neutral rating on the ...
Top Stock Movers Now: Constellation Brands, IDEXX, Tyson Foods, and More
IDEXX Laboratories ( IDXX) was the best-performing stock in the S&P 500 after the provider of veterinary healthcare products ...
Idexx: Q4 EPS, Revenue Beat Forecast
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
Idexx Laboratories price target raised to $520 from $481 at Barclays
Barclays raised the firm’s price target on Idexx Laboratories (IDXX) to $520 from $481 and keeps an Overweight rating on the shares. The ...
Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits
IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...
American Association of Individual Investors1d
Why IDEXX Laboratories, Inc.’s (IDXX) Stock Is Up 11.13%
IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...
IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...
Stifel上调IDEXX股票目标价至460美元
周一，Stifel分析师调整了IDEXX ...
BTIG将IDEXX目标股价上调至530美元
周一，BTIG分析师Mark Massaro宣布将IDEXX Laboratories (NASDAQ: IDXX )的目标股价从500美元上调至530美元，同时维持对该股票的买入评级。此次调整是在IDEXX第四季度业绩超出收入和盈利预期后做出的。目前，该公司市值为385亿美元，股价为469.04美元，InvestingPro分析显示该股票的交易价格高于其公允价值。